Key result
Comorbid hypertension linked to ~4.7-fold higher odds of elevated 10-year CVD risk in diabetes.
Why the study?
What are the prevalence patterns and independent clinical determinants of elevated 10-year cardiovascular disease risk (≥10%) among adults with type 2 diabetes mellitus receiving specialized care in Nigeria?
Cross-Sectional (n=150)
No
What are the prevalence patterns and independent clinical determinants of elevated 10-year cardiovascular disease risk (≥10%) among adults with type 2 diabetes mellitus receiving specialized care in Nigeria?
Answers are grounded in this paper and cite their sources.
Despite receiving specialized tertiary care in Nigeria, 42.7% of patients with type 2 diabetes had an elevated 10-year CVD risk (≥10%), driven primarily by co-morbid hypertension and longer diabetes duration, highlighting the need for more aggressive cardiovascular risk management.
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among individuals with type 2 diabetes mellitus (T2DM), especially in low- and middle-income countries. Understanding the pattern and determinants of CVD risk in these settings is essential to improving diabetes care and reducing CVD-related morbidity and mortality. This study investigated the patterns and determinants of CVD risk among T2DM patients receiving specialized diabetes care in Nigeria, with the aim of informing effective risk evaluation and management. A hospital-based cross-sectional study was conducted among 150 randomly selected T2DM patients. Demographic, clinical, and biochemical data were collected using structured research proforma. A 10-year CVD risk was assessed using updated World Health Organization (WHO) laboratory-based CVD risk assessment chart. Data analysis was performed using the Statistical Package for the Social Sciences (SPSS) version 25. Chi-square, independent samples t-test and Mann-Whitney U tests were used to compare variables across risk groups where applicable, while binary logistic regression was employed to identify significant determinants of CVD risk. Among the study participants, 57.3% ( n = 86) had low CVD risk (< 10%), while 42.7% ( n = 64) had elevated risk (≥ 10%). Longer duration of diabetes (AOR = 1.26, 95% CI: 1.15–1.39; p < 0.001) and the presence of co-morbid hypertension (AOR = 4.69, 95% CI: 1.81–12.19; p = 0.002) were the significant determinants of CVD risk status in the study population. There is a high burden of moderate-to-high CVD risk in the study population, with longer diabetes duration and co-morbid hypertension identified as key determinants. These findings highlight persistent cardiovascular risk despite specialized diabetes care, reinforcing the need for more comprehensive and sustained management strategies, particularly in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus (n=150). Co-morbid hypertension and longer duration of diabetes vs. Absence of co-morbid hypertension and shorter duration of diabetes was evaluated on Elevated 10-year cardiovascular disease risk (>=10%) assessed by the updated WHO laboratory-based CVD risk assessment chart (AOR 4.69, 95% CI 1.81-12.19, p=0.002). Co-morbid hypertension and longer diabetes duration independently predicted elevated 10-year CVD risk, present in 42.7% of patients.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: